Revolution Medicines
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2015-01-01
- Employees
- 378
- Market Cap
- $7.2B
- Website
- http://www.revmed.com
- Introduction
Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanis...
Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors
- First Posted Date
- 2018-08-17
- Last Posted Date
- 2022-09-01
- Lead Sponsor
- Revolution Medicines, Inc.
- Target Recruit Count
- 133
- Registration Number
- NCT03634982
- Locations
- 🇺🇸
UC San Francisco - Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States
🇺🇸Sarah Cannon Research Institute - Florida Cancer Specialists, Sarasota, Florida, United States
🇺🇸Sarah Cannon Research Institute - Tennessee Oncology, PLLC, Nashville, Tennessee, United States
© Copyright 2024. All Rights Reserved by MedPath